enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Dextromethorphan - Wikipedia

   en.wikipedia.org/wiki/Dextromethorphan

   Dextromethorphan, sold under the brand name Robitussin among others, is a cough suppressant used in many cough and cold medicines. [6] In 2022, the US Food and Drug Administration (FDA) approved the combination dextromethorphan/bupropion to serve as a rapid-acting antidepressant in people with major depressive disorder .

3. Recreational use of dextromethorphan - Wikipedia

   en.wikipedia.org/wiki/Recreational_use_of_dext...

   Due to dextromethorphan's selective serotonin reuptake inhibitor-like action, the sudden cessation of recreational dosing in tolerant individuals can result in mental and physical withdrawal symptoms similar to the withdrawal from SSRIs. These withdrawal effects can manifest as psychological effects, including depression, irritability, cravings ...

4. Cold medicine - Wikipedia

   en.wikipedia.org/wiki/Cold_medicine

   In 2022, the deaths of 66 children in The Gambia were linked to four pediatric cough syrup medications that contained diethylene glycol and ethylene glycol. [ 44 ] [ 45 ] In 2022, the US Food and Drug Administration issued a warning against cooking foods in cough syrup after a video of someone preparing "NyQuil chicken", sometimes also called ...

5. Robitussin Cough Syrups Have Been Recalled - AOL

   www.aol.com/robitussin-cough-syrups-recalled...

   Robitussin Honey CF Max NT Adult 8oz Lots: T08740 (June 30, 2026), T08742 (June 30, 2026) The elderly and very young people are most likely to experience complications from fungemia.

6. Robitussin maker settles lawsuit in US over 'non-drowsy' claim

   www.aol.com/news/robitussin-maker-settles...

   The maker of Robitussin settled a consumer lawsuit that claimed its "non-drowsy" cough and flu medicine causes drowsiness, agreeing to pay $4.5 million and remove the "non-drowsy" claim from its ...

7. Dextromethorphan/bupropion - Wikipedia

   en.wikipedia.org/wiki/Dextromethorphan/bupropion

   In Study 1 (GEMINI), a 6-week randomized controlled trial of dextromethorphan/bupropion versus placebo in people with major depressive disorder, scores on the Montgomery–Åsberg Depression Rating Scale (MADRS)—a scale with a range of 0 to 60 points—decreased with dextromethorphan/bupropion by 15.9 points from a baseline score of 33.6 ...